Pulmonary drug delivery systems refer to the technologies that are used to treat diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis using pulmonary route of drug administration.
Based on the Pulmonary Drug Delivery Devices market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Pulmonary Drug Delivery Devices market covered in Chapter 5:
Nypro Healthcare
Koninklijke Philips N.V.
Novartis AG
Omron Corp.
F. Hoffmann-La Roche
Hovione
AstraZeneca
GlaxoSmithKline
Bristol-Myers Squibb
Chiesi Farmaceutici S.P.A.
Merck & Co. Inc.
Sunovion Pharmaceuticals
Gerresheimer AG
Boehringer Ingelheim GmbH
3M Healthcare
Bespak
Mylan N.V.
MannKind
AptarGroup
Teva Pharmaceutical Industries
SHL Group
In Chapter 6, on the basis of types, the Pulmonary Drug Delivery Devices market from 2015 to 2025 is primarily split into:
Metered Dose Inhalers (MDI)
Dry Powder Inhalers (DPI)
Nebulizers
In Chapter 7, on the basis of applications, the Pulmonary Drug Delivery Devices market from 2015 to 2025 covers:
Asthma
COPD
Cystic Fibrosis
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Pulmonary Drug Delivery Devices Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Nypro Healthcare
5.1.1 Nypro Healthcare Company Profile
5.1.2 Nypro Healthcare Business Overview
5.1.3 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Nypro Healthcare Pulmonary Drug Delivery Devices Products Introduction
5.2 Koninklijke Philips N.V.
5.2.1 Koninklijke Philips N.V. Company Profile
5.2.2 Koninklijke Philips N.V. Business Overview
5.2.3 Koninklijke Philips N.V. Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Koninklijke Philips N.V. Pulmonary Drug Delivery Devices Products Introduction
5.3 Novartis AG
5.3.1 Novartis AG Company Profile
5.3.2 Novartis AG Business Overview
5.3.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Novartis AG Pulmonary Drug Delivery Devices Products Introduction
5.4 Omron Corp.
5.4.1 Omron Corp. Company Profile
5.4.2 Omron Corp. Business Overview
5.4.3 Omron Corp. Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Omron Corp. Pulmonary Drug Delivery Devices Products Introduction
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Company Profile
5.5.2 F. Hoffmann-La Roche Business Overview
5.5.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Products Introduction
5.6 Hovione
5.6.1 Hovione Company Profile
5.6.2 Hovione Business Overview
5.6.3 Hovione Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Hovione Pulmonary Drug Delivery Devices Products Introduction
5.7 AstraZeneca
5.7.1 AstraZeneca Company Profile
5.7.2 AstraZeneca Business Overview
5.7.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 AstraZeneca Pulmonary Drug Delivery Devices Products Introduction
5.8 GlaxoSmithKline
5.8.1 GlaxoSmithKline Company Profile
5.8.2 GlaxoSmithKline Business Overview
5.8.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Products Introduction
5.9 Bristol-Myers Squibb
5.9.1 Bristol-Myers Squibb Company Profile
5.9.2 Bristol-Myers Squibb Business Overview
5.9.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Products Introduction
5.10 Chiesi Farmaceutici S.P.A.
5.10.1 Chiesi Farmaceutici S.P.A. Company Profile
5.10.2 Chiesi Farmaceutici S.P.A. Business Overview
5.10.3 Chiesi Farmaceutici S.P.A. Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Chiesi Farmaceutici S.P.A. Pulmonary Drug Delivery Devices Products Introduction
5.11 Merck & Co. Inc.
5.11.1 Merck & Co. Inc. Company Profile
5.11.2 Merck & Co. Inc. Business Overview
5.11.3 Merck & Co. Inc. Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Merck & Co. Inc. Pulmonary Drug Delivery Devices Products Introduction
5.12 Sunovion Pharmaceuticals
5.12.1 Sunovion Pharmaceuticals Company Profile
5.12.2 Sunovion Pharmaceuticals Business Overview
5.12.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Products Introduction
5.13 Gerresheimer AG
5.13.1 Gerresheimer AG Company Profile
5.13.2 Gerresheimer AG Business Overview
5.13.3 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Gerresheimer AG Pulmonary Drug Delivery Devices Products Introduction
5.14 Boehringer Ingelheim GmbH
5.14.1 Boehringer Ingelheim GmbH Company Profile
5.14.2 Boehringer Ingelheim GmbH Business Overview
5.14.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Products Introduction
5.15 3M Healthcare
5.15.1 3M Healthcare Company Profile
5.15.2 3M Healthcare Business Overview
5.15.3 3M Healthcare Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 3M Healthcare Pulmonary Drug Delivery Devices Products Introduction
5.16 Bespak
5.16.1 Bespak Company Profile
5.16.2 Bespak Business Overview
5.16.3 Bespak Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Bespak Pulmonary Drug Delivery Devices Products Introduction
5.17 Mylan N.V.
5.17.1 Mylan N.V. Company Profile
5.17.2 Mylan N.V. Business Overview
5.17.3 Mylan N.V. Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Mylan N.V. Pulmonary Drug Delivery Devices Products Introduction
5.18 MannKind
5.18.1 MannKind Company Profile
5.18.2 MannKind Business Overview
5.18.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 MannKind Pulmonary Drug Delivery Devices Products Introduction
5.19 AptarGroup
5.19.1 AptarGroup Company Profile
5.19.2 AptarGroup Business Overview
5.19.3 AptarGroup Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 AptarGroup Pulmonary Drug Delivery Devices Products Introduction
5.20 Teva Pharmaceutical Industries
5.20.1 Teva Pharmaceutical Industries Company Profile
5.20.2 Teva Pharmaceutical Industries Business Overview
5.20.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Products Introduction
5.21 SHL Group
5.21.1 SHL Group Company Profile
5.21.2 SHL Group Business Overview
5.21.3 SHL Group Pulmonary Drug Delivery Devices Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.21.4 SHL Group Pulmonary Drug Delivery Devices Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Pulmonary Drug Delivery Devices Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Pulmonary Drug Delivery Devices Sales and Market Share by Types (2015-2020)
6.1.2 Global Pulmonary Drug Delivery Devices Revenue and Market Share by Types (2015-2020)
6.1.3 Global Pulmonary Drug Delivery Devices Price by Types (2015-2020)
6.2 Global Pulmonary Drug Delivery Devices Market Forecast by Types (2020-2025)
6.2.1 Global Pulmonary Drug Delivery Devices Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Pulmonary Drug Delivery Devices Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Pulmonary Drug Delivery Devices Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Pulmonary Drug Delivery Devices Sales, Price and Growth Rate of Metered Dose Inhalers (MDI)
6.3.2 Global Pulmonary Drug Delivery Devices Sales, Price and Growth Rate of Dry Powder Inhalers (DPI)
6.3.3 Global Pulmonary Drug Delivery Devices Sales, Price and Growth Rate of Nebulizers
6.4 Global Pulmonary Drug Delivery Devices Market Revenue and Sales Forecast, by Types (2020-2025)
Summary: Get latest Market Research Reports on Pulmonary Drug Delivery Devices. Industry analysis & Market Report on Pulmonary Drug Delivery Devices is a syndicated market report, published as Global Pulmonary Drug Delivery Devices Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Pulmonary Drug Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.